Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "The current situation of intensive care units in Chinese mainland: A nationwide survey" [Journal of Intensive Medicine volume 2 (2026) 132-140].

Journal of intensive medicine·2026
Same author

A Cross-Species Single-Cell Transcriptomic Atlas of Subcutaneous Adipose Tissue Reveals Conserved and Divergent Cellular Programs.

Animal genetics·2026
Same author

Video-Based Training on Physicians' Proficiency in Invasive Fungal Disease: A Multicentre, Cluster Randomised Controlled Trial.

Mycoses·2026
Same author

MYC-Driven Glycolysis in TNFRSF4+ CD4+ T Cells Underlies Heightened Rejection Susceptibility of Cardiac vs. Renal Allografts.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Response Surface Modeling and Parameter Optimization of Microgroove Depth in Water-Jet-Guided Laser Machining of L605 Alloy.

Micromachines·2026
Same author

Corrigendum to "Seeing Artery and VEin Simultaneously in the long axis (SAVES) for ultrasound-guided infraclavicular axillary/subclavian vein cannulation: A retrospective analysis" [Journal of Intensive Medicine volume 4 (2025) 350-358.].

Journal of intensive medicine·2026
Same journal

Correction to: A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice.

BMC systems biology·2019
Same journal

Predicting disease-related phenotypes using an integrated phenotype similarity measurement based on HPO.

BMC systems biology·2019
Same journal

Fusing gene expressions and transitive protein-protein interactions for inference of gene regulatory networks.

BMC systems biology·2019
Same journal

A fast and efficient count-based matrix factorization method for detecting cell types from single-cell RNAseq data.

BMC systems biology·2019
Same journal

GNE: a deep learning framework for gene network inference by aggregating biological information.

BMC systems biology·2019
Same journal

FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs.

BMC systems biology·2019
See all related articles

Related Experiment Video

Updated: May 2, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

966

On an ensemble algorithm for clustering cancer patient data.

Ran Qi, Dengyuan Wu, Li Sheng

    BMC Systems Biology
    |February 26, 2014
    PubMed
    Summary
    This summary is machine-generated.

    The ensemble algorithm for clustering cancer data (EACCD) effectively clusters breast cancer patient data, improving prognostic accuracy beyond traditional TNM staging. Analysis confirms its robustness and potential for enhanced cancer outcome prediction.

    More Related Videos

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    8.6K
    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
    08:08

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

    Published on: February 27, 2015

    20.2K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
    08:25

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

    Published on: April 25, 2025

    966
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    8.6K
    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
    08:08

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

    Published on: February 27, 2015

    20.2K

    Area of Science:

    • Oncology
    • Bioinformatics
    • Computational Biology

    Background:

    • The TNM staging system, based on Tumor, Node, Metastasis, is insufficient as cancer is not purely anatomic.
    • Expanding TNM with new prognostic factors is crucial for accurate cancer patient outcome estimation.
    • The ensemble algorithm for clustering cancer data (EACCD) aims to enhance TNM without altering its core definitions.

    Purpose of the Study:

    • To analyze the ensemble algorithm for clustering cancer data (EACCD) using a large breast cancer patient dataset.
    • To compare EACCD's output with survival curves and evaluate the impact of its various settings.
    • To assess EACCD's performance against alternative clustering approaches.

    Main Methods:

    • Utilized a large breast cancer patient dataset for EACCD analysis.
    • Generated dendrograms to visualize relationships between patient survival curves.
    • Investigated the influence of different EACCD parameters, including linkage functions and statistical tests.
    • Evaluated the necessity of the dissimilarity learning step within EACCD.
    • Compared EACCD with other clustering techniques and partitioning methods.

    Main Results:

    • EACCD generated robust dendrograms reflecting patient survival curve relationships, particularly with large numbers of runs (m).
    • Dendrogram robustness is influenced by linkage functions but minimally by statistical tests for large m.
    • Omitting the dissimilarity learning step in EACCD can degrade performance.
    • Clustering solely on prognostic factors or using direct partitioning methods may yield misleading results.

    Conclusions:

    • EACCD effectively clusters cancer patient data when utilizing the Partitioning Around Medoids (PAM) algorithm for dissimilarity learning with sufficient runs (large m).
    • Robust dendrograms are achievable with large m values in EACCD.
    • The study validates EACCD as a valuable tool for cancer data analysis and outcome prediction.